|
AbbVie
|
179.08 |
|
4.20 |
2.40% |
10.79% |
2025-04-14 |
|
Acadia Pharmaceuticals
|
14.85 |
|
0.27 |
1.85% |
-12.08% |
2025-04-14 |
|
ALKERMES
|
27.23 |
|
0.23 |
0.85% |
11.51% |
2025-04-14 |
|
Amgen
|
293.70 |
|
7.83 |
2.74% |
10.59% |
2025-04-14 |
|
Bayer
|
20.89 |
|
0.73 |
3.62% |
-21.05% |
2025-04-14 |
|
Biogen
|
119.22 |
|
4.07 |
3.53% |
-39.44% |
2025-04-14 |
|
BioMarin Pharmaceutical
|
59.67 |
|
2.85 |
5.02% |
-34.79% |
2025-04-14 |
|
Bristol-Myers Squibb
|
51.35 |
|
0.68 |
1.34% |
5.70% |
2025-04-14 |
|
Gilead Sciences
|
106.50 |
|
2.92 |
2.82% |
57.10% |
2025-04-14 |
|
Incyte
|
59.22 |
|
2.35 |
4.13% |
10.84% |
2025-04-14 |
|
Eli Lilly
|
753.80 |
|
21.97 |
3.00% |
0.34% |
2025-04-14 |
|
Merck
|
79.03 |
|
-0.11 |
-0.14% |
-37.37% |
2025-04-14 |
|
Moderna
|
26.81 |
|
0.64 |
2.45% |
-74.20% |
2025-04-14 |
|
Neurocrine Biosciences
|
94.86 |
|
3.99 |
4.39% |
-27.99% |
2025-04-14 |
|
Novartis
|
88.74 |
|
2.65 |
3.08% |
2.59% |
2025-04-14 |
|
Pfizer
|
22.09 |
|
0.20 |
0.91% |
-14.71% |
2025-04-14 |
|
PTC Therapeutics
|
45.08 |
|
2.10 |
4.89% |
75.55% |
2025-04-14 |
|
Ultragenyx Pharmaceutical
|
34.92 |
|
0.78 |
2.28% |
-18.54% |
2025-04-14 |
|
Regeneron Pharmaceuticals
|
570.58 |
|
16.82 |
3.04% |
-36.49% |
2025-04-14 |
|
Sanofi
|
91.88 |
|
2.26 |
2.52% |
5.07% |
2025-04-14 |
|
Sanofi
|
51.84 |
|
2.13 |
4.27% |
12.88% |
2025-04-14 |
|
Sarepta Therapeutics
|
54.63 |
|
3.60 |
7.05% |
-53.82% |
2025-04-14 |
|
Teva Pharmaceutical Industries
|
5,060.00 |
|
51.00 |
1.02% |
1.61% |
2025-04-14 |
|
United Therapeutics
|
284.31 |
|
3.15 |
1.12% |
20.94% |
2025-04-14 |
|
Vertex Pharmaceuticals
|
495.91 |
|
11.89 |
2.46% |
24.76% |
2025-04-14 |